510(k) Report

510(k) · Cleared

Cleared

Accuprobe 450, Accuprobe 550/530 and the Accuprobe 600 Series

K973190510(k) TraditionalCleared Nov 21, 199788-day reviewClass II21 CFR 878.4400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cryomedical Sciences, Inc. · GEI Electrosurgical, Cutting & Coagulation & Accessories

Cleared on Nov 21, 1997 after an 88-day review. The FDA summary names its predicate without a number. 122 later devices descend from it.

Decided
Nov 21, 1997
Review
88 days
Class
Class II
Product code
GEI
Recalls
None
Predicates
0

122 later devices descend from it, 6 citing it directly.

Descendants, by year cleared 2004: 3 descendants cleared2006: 11 descendants cleared2007: 5 descendants cleared1998: 1 descendant cleared2008: 10 descendants cleared2012: 7 descendants cleared2009: 3 descendants cleared2010: 4 descendants cleared2001: 1 descendant cleared2002: 1 descendant cleared2011: 4 descendants cleared2014: 6 descendants cleared2019: 10 descendants cleared2013: 2 descendants cleared2003: 1 descendant cleared2005: 2 descendants cleared2018: 6 descendants cleared2021: 3 descendants cleared2022: 5 descendants cleared2015: 4 descendants cleared2016: 5 descendants cleared2024: 8 descendants cleared2020: 4 descendants cleared2026: 5 descendants cleared2025: 3 descendants cleared2017: 6 descendants cleared2023: 2 descendants cleared1995200020052010201520202025
  1. This deviceK973190 Accuprobe 450, Accuprobe 550/530 and the Accuprobe 600 SeriesCryomedical Sciences, Inc. · 1997
  2. Descendant · cites it directly · 93 of its ownK980110 Endocre Cryocare Cryosurgical SystemEndocare, Inc. · 1998
  3. Descendant · 2 generations on · 92 of its ownK011722 Atricure Bipolar Coagulation SystemAtriCure, Inc. · 2001
  4. Descendant · 3 generations on · 90 of its ownK020919 Atricure Bipolar System, Models ASU1, ASU2, ASU3, LHP1, LHP2, RHP1AtriCure, Inc. · 2002
  5. Descendant · cites it directly · 42 of its ownK040690 Surgifrost 10 CM Cryosurgical Device Plus Frostbyte Clamp and…Cryocath Technologies, Inc. · 2004
  6. Descendant · 4 generations on · 34 of its ownK031247 Cardioblate Bipolar Radiofrequency Surgical Ablation SystemMedtronic Vascular · 2003

Showing 5 of 122 descendants. See all descendants

Descendants cleared per year

1998: 12001: 12002: 12003: 12004: 32005: 22006: 112007: 52008: 102009: 32010: 42011: 42012: 72013: 22014: 62015: 42016: 52017: 62018: 62019: 102020: 42021: 32022: 52023: 22024: 82025: 32026: 5
1998high 11 (2006) · low 0 (1999)2026

Most influential descendants

Showing 5 of 122 · See all
  • K980110Endocre Cryocare Cryosurgical SystemEndocare, Inc. · 1998 · cites it directly93descendants
  • K011722Atricure Bipolar Coagulation SystemAtriCure, Inc. · 2001 · 2 generations on92descendants
  • K020919Atricure Bipolar System, Models ASU1, ASU2, ASU3, LHP1, LHP2, RHP1AtriCure, Inc. · 2002 · 3 generations on90descendants
  • K040690Surgifrost 10 CM Cryosurgical Device Plus Frostbyte Clamp and Cryosurgical ConsoleCryocath Technologies, Inc. · 2004 · cites it directly42descendants
  • K031247Cardioblate Bipolar Radiofrequency Surgical Ablation SystemMedtronic Vascular · 2003 · 4 generations on34descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K973190Accuprobe 450, Accuprobe 550/530 and the Accuprobe 600 SeriesCryomedical Sciences, Inc.1997—
+1K980110Endocre Cryocare Cryosurgical SystemEndocare, Inc.1998—
+2K011722Atricure Bipolar Coagulation SystemAtriCure, Inc.2001—
+3K020919Atricure Bipolar System, Models ASU1, ASU2, ASU3, LHP1, LHP2, RHP1AtriCure, Inc.2002—
+1K040690Surgifrost 10 CM Cryosurgical Device Plus Frostbyte Clamp and Cryosurgical…Cryocath Technologies, Inc.2004—
+4K031247Cardioblate Bipolar Radiofrequency Surgical Ablation SystemMedtronic Vascular2003—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199810
200110
200210
200310
200430
200520
2006110
200750
2008100
200930
201040
201140
201270
201320
201460
201540
201650
201760
201860
2019100
202040
202130
202250
202320
202480
202530
202650
FIG. 1 — Lineage of K973190, 1997–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEI device

  1. #1 K231790 The InMode System with the Morpheus8 Applicatorsscore 32.7 · 21 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (11)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Frigitronics Model Zacarian C-21
Named without a submission number
—
*—Frigitronics Model Cryo-Surg
Named without a submission number
—
*—Frigitronics Models CM-73 and CT-82
Named without a submission number
—
*—Frigitronics Model CE-4G
Named without a submission number
—
*—Frigitronics Models CS-76 and CE-8
Named without a submission number
—
*—ERBE Erbokryo
Named without a submission number
—
*—Candela Cryotech Models LCS 2000 and 3000
Named without a submission number
—
*—Brymill Corporation Kryospray
Named without a submission number
—
*—Physicians Products, Inc. spray container
Named without a submission number
—
*—Spembly Medical 130 Cryounit
Named without a submission number
—
*—Cabot Medical's Models MT-700, MT750, FT-350 and MC-8000
Named without a submission number
—

What descends from it? (122)

See all 122

6 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K980110Endocre Cryocare Cryosurgical SystemEndocare, Inc.199893
K040690Surgifrost 10 CM Cryosurgical Device Plus Frostbyte Clamp and Cryosurgical ConsoleCryocath Technologies, Inc.200442
K072883Ice-SenseArbel Medical, Ltd.200726
K053436Surgifrost 6CM, 7CM and 10 CM Cryosurgical Devices Plus Frostbyte Clamp and Cryosurgical…Cryocath Technologies, Inc.200622
K062140Surgifrost XL Cryosurgical Device, Model 60SFXL; Cryosurgical Console, Model 65CS1Cryocath Technologies, Inc.20061
K062175Cryocare CN2 SystemEndocare, Inc.20060

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K980110 (Endocare, Inc., 1998) has gone furthest, with 93 descendants of its own.

How does its category compare?

All GEI devices

GEI Electrosurgical, Cutting & Coagulation & Accessories: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GEI

52in 2025

2007: 502008: 612009: 422010: 462011: 352012: 392013: 482014: 492015: 472016: 642017: 522018: 472019: 482020: 592021: 462022: 552023: 652024: 592025: 522026 (partial year): 43
2007high 65 (2023) · low 35 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEI

113in 2025

2007: 51 days median2008: 71 days median2009: 130 days median2010: 109 days median2011: 135 days median2012: 133 days median2013: 136 days median2014: 103 days median2015: 123 days median2016: 108 days median2017: 72 days median2018: 93 days median2019: 93 days median2020: 105 days median2021: 146 days median2022: 150 days median2023: 104 days median2024: 125 days median2025: 113 days median2026 (partial year): 183 days median
2007high 183 (2026) · low 51 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEI

4in 2025

2007: 212008: 192009: 272010: 512011: 322012: 302013: 132014: 32015: 42016: 32017: 22018: 62019: 52020: 12021: 62022: 492023: 27, 4 Class I2024: 22, 10 Class I2025: 42026 (partial year): 8
2007high 51 (2010) · low 1 (2020)2026

Class I (14 since 2007) Class II/III not classified

Adverse event reports per year · GEI

7,592in 2025

2007: 2,7952008: 2,5562009: 3,5912010: 3,3772011: 4,4632012: 5,2162013: 4,8972014: 4,9082015: 4,9362016: 5,6162017: 6,0732018: 6,5452019: 7,0672020: 6,4902021: 6,3542022: 6,1032023: 7,1762024: 7,8972025: 7,592
2007high 7,897 (2024) · low 2,556 (2008)2025

MAUDE reports naming product code GEI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20075051212,795
20086171192,556
200942130273,591
201046109513,377
201135135324,463
201239133305,216
201348136134,897
20144910334,908
20154712344,936
20166410835,616
2017527226,073
2018479366,545
2019489357,067
20205910516,490
20214614666,354
202255150496,103
20236510427 (4)7,176
20245912522 (10)7,897
20255211347,592
2026431838—

What is it indicated for?

Each proposed intended use description will have the letter (A ) which represents any of the family of AccuProbe® devices, the AccuProbe® 450, AccuProbe® 550/530 and the AccuProbe® 600 Series inclusive. Urology . The (A) system may be used to ablate prostatic tissue. . The (A) system may be used for the ablation of prostate tissue in cases of prostate cancer and benign prostatic hyperplasia.. Oncology . The (A) system may be used for ablation of…

Read the full statement (297 words)

Each proposed intended use description will have the letter (A ) which represents any of the family of AccuProbe® devices, the AccuProbe® 450, AccuProbe® 550/530 and the AccuProbe® 600 Series inclusive.

Urology

. The (A) system may be used to ablate prostatic tissue.

. The (A) system may be used for the ablation of prostate tissue in cases of prostate cancer and benign prostatic hyperplasia..

Oncology

. The (A) system may be used for ablation of cancerous or malignant tissue.

. The (A) system may be used for ablation of benign tumors.

. The (A) system may be used for palliative intervention.

Dermatology

. The (A) system may be used for the ablation or freezing of skin cancers and other cutaneous disorders.

Gynecology

. The (A) system may be used for the ablation of malignant neoplasia or benign dysplasia of the female genitalia.

General Surgery

. The (A) system may be used for the ablation of leukoplakia of mouth, angiomas, sebaceous hyperpalsia, basal cell tumors of the eyelid or canthus areq, ulcerated basal cell tumors, dermatofibromas, small hemangiomas, mucocele cysts, multiple warts, plantar warts, hemorrhoids, anal fissures, peri-anal condylomata, pilonidal cysts, actinic and seborrheic keratoses , cavernous hemangiomas, recurrent cancerous lesions.

o The (A) system may be used for the destruction of warts or lesions.

o The (A) system may be used for the palliation of tumors of the oral cavity, rectum, breast, and skin.

Thoracic Surgery

. The (A) system may be used for the ablation of arrhythmic cardiac tissue.

. The (A) system may be used for the ablation of cancerous lesions.

Proctology

o The (A) system may be used for the ablation of benign or malignant growths of the anus and rectum

o The (A) systems may be used for the ablation of hemorrhoids.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K973190: Accuprobe 450, Accuprobe 550/530 and the Accuprobe 600 Series.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K973190

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026